Bioethics and research: case study analysis. of Ebola virus epidemic in 2014
Bioética e investigación: análisis de caso de la epidemia por el virus del ébola en 2014;
Bioética e investigação: análise de caso epidemia. do vírus ebola em 2014
dc.creator | Pinto, Boris Julian | |
dc.creator | Gómez Córdoba, Ana Isabel | |
dc.creator | Wintaco, Luz Maira | |
dc.creator | Amador, Diana Patricia | |
dc.creator | González, Germán Andrés | |
dc.creator | Carabalí, Mary Lilián | |
dc.creator | Ararat Sarria, Mónica | |
dc.creator | Olaya, Nury Natalia | |
dc.creator | Patiño, Luz Helena | |
dc.creator | Sanabria, Alfredo José | |
dc.date.accessioned | 2020-01-08T19:33:46Z | |
dc.date.accessioned | 2022-09-28T21:22:19Z | |
dc.date.available | 2020-01-08T19:33:46Z | |
dc.date.available | 2022-09-28T21:22:19Z | |
dc.date.created | 2020-01-08T19:33:46Z | |
dc.identifier | http://hdl.handle.net/10654/34273 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3744245 | |
dc.publisher | Universidad Militar Nueva Granada | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/2156 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/2570 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3104 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3105 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3106 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3107 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3108 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3109 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3110 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3111 | |
dc.relation | http://revistas.unimilitar.edu.co/index.php/rlbi/article/view/1943/3112 | |
dc.relation | /*ref*/Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone, R. et al. (2014). Randomised controlled trials for Ebola: practical and ethical issues. The Lancet, 384(9952), 1423-4. https://doi.org/10.1016/S0140-6736(14)61734-7 | |
dc.relation | /*ref*/Asociación Médica Mundial [AMM]. (2013). Declaración Helsinki, Principios éticos para las investigaciones médicas en seres humanos. 64ª Asamblea General. Fortaleza, Brasil. | |
dc.relation | /*ref*/Bausch, D.G., Sprecher, A.G., Jeffs, B., Boumandouki, P. (2008). Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. Antiviral Research, 78(1), 150-161. https://doi.org/10.1016/j.antiviral.2008.01.152 | |
dc.relation | /*ref*/Benatar, S. (2015). Explaining and responding to the Ebola epidemic. Philosophy, Ethics, and Humanities in Medicine, 10(5), 1-3. https://doi.org/10.1186/s13010-015-0027-8 | |
dc.relation | /*ref*/Bogoch, I.I., Creatore, M.I., Cetron, M.S., Brownstein, J.S. et al. (2015). Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet, 3(9962), 29-35. https://doi.org/10.1016/S0140-6736(14)61828-6 | |
dc.relation | /*ref*/Boozary, A.S., Farmer, P.E. y Jha, A.K. (2014). The Ebola Outbreak, Fragile Health Systems, and Quality as a Cure. Journal of the American Medical Association, 312(18), 1859-1860. https://doi.org/10.1001/jama.2014.14387 | |
dc.relation | /*ref*/Caplan, A.L., Plunkett, C. y Levin, B. (2015). Selecting the right tool for the job. The American Journal of Bioethics, 15(4), 4-10. https://doi.org/10.1080/15265161.2015.1010993 | |
dc.relation | /*ref*/Centers for Disease Control and Prevention [CDC] (2015a). Ebola (Ebola Virus Disease). Recuperado el 12 de noviembre de 2015, de http://www.cdc.gov/vhf/Ebola/transmission/index.html | |
dc.relation | /*ref*/Centers for Disease Control and Prevention [CDC] (2015b). Enfermedad del virus del Ebola. Prevención. Recuperado el 18 de noviembre de 2015, de http://espanol.cdc.gov/vhf/ebola/prevention/index.html | |
dc.relation | /*ref*/Check, E. (2015). Proposed Ebola biobank would strengthen African science. Nature, 524(7564), 146-147. https://doi.org/10.1038/524146a | |
dc.relation | /*ref*/Coffey, C.S., Levin, B., Clark. C., Timmerman, C. et al. (2012). Overview, hurdles, and future work in adaptive designs: Perspectives from an NIH funded workshop. Clinical Trials, 9(6), 671-680. https://doi.org/10.1177/1740774512461859 | |
dc.relation | /*ref*/Cohen, J. y Kupferschmidt, K. (2014). Ebola vaccine trials raise ethical issues: Randomized studies may offer fastest answer. Science Magazine, 346(6207), 289-290. https://doi.org/10.1126/science.346.6207.289 | |
dc.relation | /*ref*/Council for International Organizations of Medical Sciences [CIOMS] y World Health Organization [WHO] (2002). Pautas éticas internacionales para la investigación y experimentación biomédica en seres humanos de la Organización Mundial de la Salud. Ginebra, pauta número 12. Recuperado el 21 de marzo de 2016, de http://www.cioms.ch/publications/guidelines/pautas_eticas_internacionales.htm | |
dc.relation | /*ref*/Cox, E., Borio, L. y Temple R. (2014). Evaluating Ebola therapies. The case for RCTs. New England Journal of Medicine, 371(25), 2350-2351. https://doi.org/10.1056/NEJMp1414145 | |
dc.relation | /*ref*/Deaton, A. (2015). El gran escape. Salud, riqueza y el origen de la desigualdad. Madrid: Fondo de Cultura Económica. | |
dc.relation | /*ref*/Donovan, G.K. (2014). Ebola, epidemics, and ethics. What we have learned? Philosophy, Ethics and Humanities in Medicine, 9(15), 2-4. https://doi.org/10.1186/1747-5341-9-15 | |
dc.relation | /*ref*/Emanuel, E. (1999). ¿Qué hace que la investigación clínica sea ética? Siete requisitos éticos. En A. Pellegrini Filho y R. Macklin (Eds.), Investigación en sujetos humanos: experiencia internacional (pp. 33-46). Santiago: Organización Panamericana de la Salud. | |
dc.relation | /*ref*/Emanuel, E.J., Wendler, D. y Grady, C. (2008). An Ethical Framework for Biomedical Research. En J. Emanuel, C. Grady, R. Crouch, R. y F. Lie (Eds.), The Oxford textbook of clinical research ethics. Oxford: Oxford University Press. | |
dc.relation | /*ref*/Farmer, P.E. (2014). Diary. London Review of Books, 36(20), 38-39. Recuperado el 18 de diciembre de 2015, de http://www.lrb.co.uk/v36/n20/paul-farmer/diary | |
dc.relation | /*ref*/Feldmann, H., Klenk, H.D. y Sanchez, A. (1993). Molecular biology and evolution of filoviruses. Archives Virology, 7, 81-100. https://doi.org/10.1007/978-3-7091-9300-6_8 | |
dc.relation | /*ref*/Frieden, T.R., Damon, I., Bell, B.P., Kenyon, T. y Nichol, S. (2014). Ebola 2014. New Challenges, New Global Response and Responsibility. New England Journal of Medicine, 371, 1177-1180. https://doi.org/10.1056/NEJMp1409903 | |
dc.relation | /*ref*/Folayan, M.O. y Haire, B. (2015). Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries. Pan African Medical Journal, 22(Suppl 1), 8. | |
dc.relation | /*ref*/Folayan, M.O, Peterson, K. y Kombe, F. (2015). Ethics, emergencies and Ebola clinical trials: the role of governments and communities in offshored research. Pan African Medical Journal, 22(Supp 1), 10. | |
dc.relation | /*ref*/Folayan, M.O., Yakubu, A., Haire, B., Peterson, K. (2016). Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Medical Ethics, 17(10). https://doi.org/10.1186/s12910-016-0094-4 | |
dc.relation | /*ref*/Gehring, G., Rohrmann, K., Atenchong, N. y Mittler, E. (2014). The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry. Journal of Antimicrobial Chemotherapy, 69(8), 2123-31. https://doi.org/10.1093/jac/dku091 | |
dc.relation | /*ref*/Gericke, C.A. (2015). Ebola and ethics: autopsy of a failure. BMJ, 350, h2105. https://doi.org/10.1136/bmj.h2105 | |
dc.relation | /*ref*/Gostin, L.O., Lucey, D. y Phelan, A. (2014). The Ebola Epidemic: A Global Health Emergency. JAMA, 312(11), 1095-1096. https://doi.org/10.1001/jama.2014.11176 | |
dc.relation | /*ref*/Griffiths, P.D. (2014). Ebola and ethics. Reviews in Medical Virology, 24(6), 363-364. https://doi.org/10.1002/rmv.1812 | |
dc.relation | /*ref*/Hayden, E.C. (2014). Ethical dilemma for Ebola drug trials. Nature, 515(7526), 177-178. https://doi.org/10.1038/515177a | |
dc.relation | /*ref*/Instituto de Salud Global de Barcelona [ISGlobal]. (2016). Ébola: dos a-os y 11 300 muertes después. Recuperado el 17 de marzo de 2016, de http://www.isglobal.org/Ebola | |
dc.relation | /*ref*/Jecker, N.S., Dudzinski, D.M., Diekema, D.S. y Tonelli, M. (2015). Ebola virus disease. Ethics and emergency medical response policy. Chest, 148(3), 794-800. https://doi.org/10.1378/chest.15-0135 | |
dc.relation | /*ref*/Joffe, S. (2014). Evaluating novel therapies during the Ebola Epidemic. JAMA, 312(13), 1299-1300. https://doi.org/10.1001/jama.2014.12867 | |
dc.relation | /*ref*/Kass, N. (2014). Ebola, Ethics, and Public Health: What Next? Annals of Internal Medicine, 161(10), 744-745. https://doi.org/10.7326/M14-1864 | |
dc.relation | /*ref*/Kilgore, P.E., Grabenstein, J.D., Salim, A.M., Rybak, M. (2015). Treatment of Ebola virus disease. Pharmacotherapy, 35(1), 43-53. https://doi.org/10.1002/phar.1545 | |
dc.relation | /*ref*/Komesaroff, P. y Kerridge. I. (2014). Ebola, Ethics, and the question of culture. Journal of Bioethical Inquiry, 11(4), 413-414. https://doi.org/10.1007/s11673-014-9581-9 | |
dc.relation | /*ref*/Kroll, D. (2014). Ebola 'Secret Serum': Small Biopharma, the army and Big Tobacco. Forbes-Pharma and Healthcare. Recuperado el 3 de marzo de 2016, de http://www.forbes.com/sites/davidkroll/2014/08/05/Ebola-secret-serum-small-biopharma-the-army-and-big-tobacco/ | |
dc.relation | /*ref*/Lazcano-Ponce, E., Salazar-Martínez, E., Gutiérrez-Castrellón, P., Angeles-Llerenas, A. et al. (2004). Ensayos clínicos aleatorizados: variantes, métodos de aleatorización, análisis, consideraciones éticas y regulación. Salud Pública de México, 46(6), 559-584. https://doi.org/10.1590/S0036-36342004000600012 | |
dc.relation | /*ref*/Lyon, G.M., Mehta, A.K., Varkey, J.B., Brantly, K., et al. (2014). Clinical Care of Two Patients with Ebola Virus Disease in the United States. New England Journal of Medicine, 371(25), 2402-2409. https://doi.org/10.1056/NEJMoa1409838 | |
dc.relation | /*ref*/Mackenzie, C., Rogers, W. y Dodds, S. (2014). Vulnerability. New Essays in Ethics and Feminist Philosophy. New York: Oxford University Press. | |
dc.relation | /*ref*/Mapp Biopharmaceutical. (2014). ZMapp information sheet. Recuperado el 3 de marzo de 2016, de http://www.defyrus.com/images/ZMapp-information-sheet.pdf | |
dc.relation | /*ref*/Marí Sáez, A., Kelly, A. y Brown, H. (2014). Apuntes sobre el paciente cero: antropología en los tiempos del Ébola. La marea.com. Recuperado el 21 de marzo de 2016, de http://www.lamarea.com/2014/10/09/apuntes-sobre-el-caso-paciente-cero-antropologia-en-los-tiempos-del-ebola/ | |
dc.relation | /*ref*/Marí Sáez, A., Weiss, S., Nowak, K, et al. (2015). Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Molecular Medicine, 7, 17-23. https://doi.org/10.15252/emmm.201404792 | |
dc.relation | /*ref*/Mathers, C.D., Boerma, T. y Ma Fat, D. (2009). Global and regional causes of death. British Medical Bulletin, 92, 7-32. https://doi.org/10.1093/bmb/ldp028 | |
dc.relation | /*ref*/Mathers, C.D. y Loncar, D. (2006). Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Medicine, 3(11), e442. https://doi.org/10.1371/journal.pmed.0030442 | |
dc.relation | /*ref*/McCarthy, M. (2014). US signs contract with ZMapp maker to accelerate development of the Ebola drug. BMJ, 349, g5488. https://doi.org/10.1136/bmj.g5488 | |
dc.relation | /*ref*/Mehta, A.K., Varkey, J.B., Brantly, K., Pérez, C.E. y Faccini-Martínez, A.A. (2015). Epidemia de Ebola-201: enfocar los esfuerzos en el control desde su epicentro. Revista Panamericana de Infectología, 17(1), 5-6. | |
dc.relation | /*ref*/Meltzer, L. y Childress, J. (2008). What is a fair participant selection? (capítulo 35) En E. J. Emanuel, C. Grady, R. Crouch et al. (Eds.), The Oxford textbook of clinical research ethics (pp. 377-383). Oxford: Oxford University Press. | |
dc.relation | /*ref*/Mickleburgh, S., Waylen, K. y Racey, P. (2009). Bats as bushmeat: a global review. Oryx, 43, 217-234. https://doi.org/10.1017/S0030605308000938 | |
dc.relation | /*ref*/Morley, F. y Macleod, R. (2015). The Halifax Index 2015. An economic gut check with insights for action. (2015). Halifax partnership. Connect, collaborate, prosper. Recuperado el 21 de marzo de 2016, de http://www.halifaxpartnership.com/site/media/Parent/8x10_HalifaxIndex2015_June18_Web.pdf | |
dc.relation | /*ref*/Murray, C.J.L., Rosenfeld, L.C., Lim, S.S., Andrews, K.G. et al. (2012). Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet, 379(9814), 413-431.https://doi.org/10.1016/S0140-6736(12)60034-8 | |
dc.relation | /*ref*/Nkoghé, D., Formenty, P., Nnégué, S., Toung Mvé, M. et al. (2004). Recommandations pratiques pour la prise en charge sur le terrain des patients infectés par le virus Ebola. Médecine Tropicale, 64(2), 199-204. | |
dc.relation | /*ref*/Organización Mundial de la Salud [OMS] (2014a). Consideraciones éticas sobre el uso de intervenciones no registradas en la enfermedad por el virus del Ébola. Recuperado el 12 de octubre de 2015, de http://www.who.int/mediacentre/news/statements/2014/Ebola-ethical-review-summary/es/ | |
dc.relation | /*ref*/Organización Mundial de la Salud [OMS] (2014b). Statement on the WHO Consultation on potential Ebola therapies and vaccines. Recuperado el 21 de marzo de 2016, de http://www.who.int/mediacentre/news/statements/2014/Ebola-therapies-consultation/en/ | |
dc.relation | /*ref*/Organización Mundial de la Salud [OMS]. (2015a). Ebola Virus Disease. Recuperado el 26 de febrero de 2016, de http://www.who.int/mediacentre/factsheets/fs103/en/ | |
dc.relation | /*ref*/Organización Mundial de la Salud [OMS] (2015b). Ebola Situation Reports. Recuperado el 15 de diciembre de 2015, de http://apps.who.int/Ebola/Ebola-situation-reports | |
dc.relation | /*ref*/Organización Mundial de la Salud [OMS] (2015c). Ebola data and satistics. Key indicators relevant to Ebola outbreak. Recuperado el 12 de noviembre de 2015, de http://apps.who.int/gho/data/node.Ebola.keyind?lang=en | |
dc.relation | /*ref*/Pinto, B.J., Mojica, M.C., Gulfo, R., Endo, J.H., y Idárraga, J. (2014). Bioética y la brecha 10/90: fallos, desafíos y oportunidades. Revista Redbioética, 2(10), 81-93. | |
dc.relation | /*ref*/Presidential Commission for the Study of Bioethical Issues. (2015). Ethics and Ebola Public Health Planning and Response. Recuperado el 16 de diciembre de 2015, de http://bioethics.gov/sites/default/files/Ethics-and-Ebola_PCSBI_508.pdf | |
dc.relation | /*ref*/Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA [ONUSIDA] (2015) Diapositivas clave sobre epidemiología, julio 2015. Recuperado el 19 de julio de 2015, de http://www.unaids.org/sites/default/files/media_asset/20150714_epi_core_es.pdf | |
dc.relation | /*ref*/Pourrut, X., Kumulungui, B., Wittmann, T., Moussavou, G. et al. (2005). The natural history of Ebola virus in Africa. Microbes and Infection, 7(7-8), 1005-1014. https://doi.org/10.1016/j.micinf.2005.04.006 | |
dc.relation | /*ref*/Qiu, X., Wong, G., Audet, J., Bello, A. et al. (2014). Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 514(7520), 47-53. https://doi.org/10.1038/nature13777 | |
dc.relation | /*ref*/Rid, A y Emanuel, E. (2014a). Why Should High-Income Countries Help Combat Ebola? JAMA, 312(13), 1297-1298. https://doi.org/10.1001/jama.2014.12869 | |
dc.relation | /*ref*/Rid, A. y Emanuel, E. (2014b). Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet, 384(9957), 1896-1899. https://doi.org/10.1016/S0140-6736(14)61315-5 | |
dc.relation | /*ref*/Rid, A. y Miller, F. (2016). Ethical Rationale for the Ebola "Ring Vaccination" Trial Design. American Journal of Public Health, 106(3), 432-5. https://doi.org/10.2105/AJPH.2015.302996 | |
dc.relation | /*ref*/Roberts, I. y Perner, A. (2014). Ebola virus disease: clinical care and patient-centred research. The Lancet, 384, 2001-2002. https://doi.org/10.1016/S0140-6736(14)62316-3 | |
dc.relation | /*ref*/Shah, S., Wendler, D. y Danis, M. (2015). Examining the ethics of clinical use of unproven interventions outside of clinical trials during the Ebola epidemic. The American Journal of Bioethics, 15(4), 11-16. https://doi.org/10.1080/15265161.2015.1010996 | |
dc.relation | /*ref*/Shaul, R.Z., Langer, J.C., McKneally, M.F. (2008). Innovación en cuidados médicos: ejemplos de cirugía. En A. Singer Peter y A. Viens (Eds.), The Cambridge Textbook of Bioethics. New York: Cambridge University Press. | |
dc.relation | /*ref*/Simonsen, S. (2012). Acceptable Risk in Biomedical Research. European Perspectives. Netherlands: Springer Science+Business Media. https://doi.org/10.1007/978-94-007-2678-9 | |
dc.relation | /*ref*/Smith, D.I.H. (1978). Ebola haemorrhagic fever in Sudan, 1976. Bulletin of the World Health Organization, 56(2), 247–270 | |
dc.relation | /*ref*/Taber, J. (2014). Hundreds of Nova Scotians volunteer for Ebola vaccine trial. The Globe and Mail. Recuperado el 21 de marzo de 2016, de http://www.theglobeandmail.com/life/health-and-fitness/health/hundreds-of-nova-scotians-volunteer-for-Ebola-vaccine-trial/article21712654 | |
dc.relation | /*ref*/United Nations Development Group [UNDG], Western and Central Africa. (2015). Socio-Economic Impact of Ebola Virus Disease in West African Countries. A call for national and regional containment, recovery and prevention. United Nations Development Group. Recuperado el 16 de noviembre de 2015, de https://undg.org/main/undg_document/socio-economic-impact-of-ebola-virus-disease-in-west-african-countries/ | |
dc.relation | /*ref*/Waldman, R. y Nieburg, P. (2015). Thoughts on Alternative Designs for Clinical Trials for Ebola Treatment Research. The American Journal of Bioethics, 15(4), 38-40. https://doi.org/10.1080/15265161.2015.1011001 | |
dc.relation | /*ref*/Yozwiak, N.L., Schaffner S.F. y Sabeti, P.C. (2015). Make outbreak research open access. Nature, 518, 477-479. https://doi.org/10.1038/518477a | |
dc.relation | /*ref*/World Health Organization Ebola Response Team[WHO-ERT] (2014). Ebola Virus Disease in West Africa - the First 9 Months of the Epidemic and Forward Projections. New England Journal of Medicine, 371, 1481-1495. | |
dc.relation | /*ref*/Zacharowski, K., Brodt, H.R. y Wolf, T. (2015). Medical treatment of an Ebola-infected doctor-ethics over costs? The Lancet, 385(9969), 685. https://doi.org/10.1016/S0140-6736(15)60279-3 | |
dc.rights | Derechos de autor 2016 Revista Latinoamericana de Bioética | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.source | Revista Latinoamericana de Bioética; Vol. 17 Núm. 32-1 (2017): COMUNICACIÓN CIENTÍFICA Y REALIDAD SOCIAL; 124-149 | |
dc.source | 2462-859X | |
dc.source | 1657-4702 | |
dc.subject | Bioethics | |
dc.subject | ebola | |
dc.subject | research ethics | |
dc.subject | vaccines | |
dc.subject | virus | |
dc.subject | Enfermedad por el virus de ébola | |
dc.subject | bioética | |
dc.subject | ética en investigación | |
dc.subject | vacunas contra el ébola | |
dc.subject | Doença pelo vírus ebola | |
dc.subject | bioética | |
dc.subject | ética em investigação | |
dc.subject | vacinas contra o ebola | |
dc.title | Bioethics and research: case study analysis. of Ebola virus epidemic in 2014 | |
dc.title | Bioética e investigación: análisis de caso de la epidemia por el virus del ébola en 2014 | |
dc.title | Bioética e investigação: análise de caso epidemia. do vírus ebola em 2014 | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:eu-repo/semantics/publishedVersion |